Clinical Trial Update: 18F-FET PET in Childhood Brain Tumours [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 18F-FET PET imaging in childhood brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• [18F]FET (O-(2-[18F]fluoroethyl)-L-tyrosine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Brain Neoplasm | Phase 2 | Status: UNKNOWN